{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:02:02Z","timestamp":1790596922727,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81960242"],"award-info":[{"award-number":["81960242"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023047","name":"Middle Tennessee State University - College of Basic and Applied Sciences","doi-asserted-by":"publisher","award":["202001AT070001"],"award-info":[{"award-number":["202001AT070001"]}],"id":[{"id":"10.13039\/100023047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016039","name":"Center for Depression Research and Clinical Care, University of Texas Southwestern Medical Center","doi-asserted-by":"publisher","award":["202102AA310069"],"award-info":[{"award-number":["202102AA310069"]}],"id":[{"id":"10.13039\/100016039","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10072-024-07729-9","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T01:02:27Z","timestamp":1724979747000},"page":"5973-5981","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cognitive function in Parkinson\u2019s disease: associations with perivascular space in basal ganglia"],"prefix":"10.1007","volume":"45","author":[{"given":"Zhenglong","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5801-5211","authenticated-orcid":false,"given":"Xinglong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"issue":"2","key":"7729_CR1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/ene.12567","volume":"22","author":"M Coelho","year":"2015","unstructured":"Coelho M et al (2015) Dementia and severity of parkinsonism determines the handicap of patients in late-stage Parkinson\u2019s disease: the Barcelona-Lisbon cohort. Eur J Neurol 22(2):305\u2013312","journal-title":"Eur J Neurol"},{"issue":"5","key":"7729_CR2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/ageing\/aft085","volume":"42","author":"AJ Yarnall","year":"2013","unstructured":"Yarnall AJ, Rochester L, Burn DJ (2013) Mild cognitive impairment in Parkinson\u2019s disease. Age Ageing 42(5):567\u2013576","journal-title":"Age Ageing"},{"issue":"10","key":"7729_CR3","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/gps.4261","volume":"30","author":"P Hobson","year":"2015","unstructured":"Hobson P, Meara J (2015) Mild cognitive impairment in Parkinson\u2019s disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort. Int J Geriatr Psychiatry 30(10):1048\u20131055","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"7729_CR4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/mds.25748","volume":"29","author":"MT Hu","year":"2014","unstructured":"Hu MT et al (2014) Predictors of cognitive impairment in an early stage Parkinson\u2019s disease cohort. Mov Disord 29(3):351\u2013359","journal-title":"Mov Disord"},{"issue":"4","key":"7729_CR5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11910-018-0823-9","volume":"18","author":"RS Weil","year":"2018","unstructured":"Weil RS, Costantini AA, Schrag AE (2018) Mild cognitive impairment in Parkinson\u2019s Disease-what is it? Curr Neurol Neurosci Rep 18(4):17","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"7729_CR6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/mds.26662","volume":"31","author":"M Delgado-Alvarado","year":"2016","unstructured":"Delgado-Alvarado M et al (2016) Biomarkers for dementia and mild cognitive impairment in Parkinson\u2019s disease. Mov Disord 31(6):861\u2013881","journal-title":"Mov Disord"},{"issue":"5","key":"7729_CR7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3174\/ajnr.A4237","volume":"36","author":"TP Hansen","year":"2015","unstructured":"Hansen TP et al (2015) Dilated perivascular spaces in the basal ganglia are a biomarker of small-vessel disease in a very elderly population with dementia. AJNR Am J Neuroradiol 36(5):893\u2013898","journal-title":"AJNR Am J Neuroradiol"},{"issue":"11","key":"7729_CR8","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/mds.27798","volume":"34","author":"YW Park","year":"2019","unstructured":"Park YW et al (2019) Magnetic resonance imaging-visible Perivascular spaces in basal Ganglia Predict Cognitive decline in Parkinson\u2019s Disease. Mov Disord 34(11):1672\u20131679","journal-title":"Mov Disord"},{"issue":"1","key":"7729_CR9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41531-021-00155-0","volume":"7","author":"T Shen","year":"2021","unstructured":"Shen T et al (2021) The role of brain perivascular space burden in early-stage Parkinson\u2019s disease. NPJ Parkinsons Dis 7(1):12","journal-title":"NPJ Parkinsons Dis"},{"issue":"Pt 9","key":"7729_CR10","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/brain\/awh553","volume":"128","author":"ND Prins","year":"2005","unstructured":"Prins ND et al (2005) Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 128(Pt 9):2034\u20132041","journal-title":"Brain"},{"issue":"6","key":"7729_CR11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/mdc3.13003","volume":"7","author":"M Dadar","year":"2020","unstructured":"Dadar M et al (2020) White Matter Hyperintensities Mediate Impact of Dysautonomia on Cognition in Parkinson\u2019s Disease. Mov Disord Clin Pract 7(6):639\u2013647","journal-title":"Mov Disord Clin Pract"},{"key":"7729_CR12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.parkreldis.2019.10.016","volume":"69","author":"U Hanning","year":"2019","unstructured":"Hanning U et al (2019) White matter hyperintensities are not associated with cognitive decline in early Parkinson\u2019s disease - the DeNoPa cohort. Parkinsonism Relat Disord 69:61\u201367","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"7729_CR13","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601","journal-title":"Mov Disord"},{"issue":"3","key":"7729_CR14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan I et al (2012) Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27(3):349\u2013356","journal-title":"Mov Disord"},{"key":"7729_CR15","doi-asserted-by":"crossref","unstructured":"Emre M et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord, 22(12): p. 1689\u2009\u2013\u2009707; quiz 1837.","DOI":"10.1002\/mds.21507"},{"issue":"3","key":"7729_CR16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. J Psychiatr Res 12(3):189\u2013198 A practical method for grading the cognitive state of patients for the clinician","journal-title":"J Psychiatr Res"},{"issue":"19","key":"7729_CR17","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/WNL.0b013e3181fc29c9","volume":"75","author":"JC Dalrymple-Alford","year":"2010","unstructured":"Dalrymple-Alford JC et al (2010) The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology 75(19):1717\u20131725","journal-title":"Neurology"},{"issue":"8","key":"7729_CR18","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM et al (2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 12(8):822\u2013838","journal-title":"Lancet Neurol"},{"issue":"3","key":"7729_CR19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/STROKEAHA.109.564914","volume":"41","author":"FN Doubal","year":"2010","unstructured":"Doubal FN et al (2010) Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke 41(3):450\u2013454","journal-title":"Stroke"},{"issue":"9","key":"7729_CR20","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/WNL.43.9.1683","volume":"43","author":"F Fazekas","year":"1993","unstructured":"Fazekas F et al (1993) Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 43(9):1683\u20131689","journal-title":"Neurology"},{"key":"7729_CR21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.clineuro.2019.04.029","volume":"182","author":"K Shibata","year":"2019","unstructured":"Shibata K et al (2019) The effect of small vessel disease on motor and cognitive function in Parkinson\u2019s disease. Clin Neurol Neurosurg 182:58\u201362","journal-title":"Clin Neurol Neurosurg"},{"key":"7729_CR22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.parkreldis.2020.12.025","volume":"83","author":"H Chen","year":"2021","unstructured":"Chen H et al (2021) Cerebral small vessel disease may worsen motor function, cognition, and mood in Parkinson\u2019s disease. Parkinsonism Relat Disord 83:86\u201392","journal-title":"Parkinsonism Relat Disord"},{"key":"7729_CR23","doi-asserted-by":"crossref","unstructured":"Zhu R et al (2022) Total Burden of Cerebral Small Vessel Disease on MRI May Predict Cognitive Impairment in Parkinson\u2019s Disease. J Clin Med, 11(18)","DOI":"10.3390\/jcm11185381"},{"issue":"6","key":"7729_CR24","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/mds.29010","volume":"37","author":"J Ramirez","year":"2022","unstructured":"Ramirez J et al (2022) Small and large magnetic resonance imaging-visible Perivascular spaces in the basal ganglia of Parkinson\u2019s Disease patients. Mov Disord 37(6):1304\u20131309","journal-title":"Mov Disord"},{"issue":"2","key":"7729_CR25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/jon.12493","volume":"28","author":"JD Rudie","year":"2018","unstructured":"Rudie JD et al (2018) Neuroimaging of dilated Perivascular spaces: from Benign and Pathologic causes to Mimics. J Neuroimaging 28(2):139\u2013149","journal-title":"J Neuroimaging"},{"issue":"1","key":"7729_CR26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/nan.12298","volume":"42","author":"K Del Tredici","year":"2016","unstructured":"Del Tredici K, Braak H (2016) Review: sporadic Parkinson\u2019s disease: development and distribution of \u03b1-synuclein pathology. Neuropathol Appl Neurobiol 42(1):33\u201350","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"7729_CR27","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ajpath.2013.12.007","volume":"184","author":"T Stewart","year":"2014","unstructured":"Stewart T et al (2014) Cerebrospinal fluid \u03b1-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort. Am J Pathol 184(4):966\u2013975","journal-title":"Am J Pathol"},{"issue":"10","key":"7729_CR28","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/jnnp-2016-314857","volume":"88","author":"CH Lin","year":"2017","unstructured":"Lin CH et al (2017) Plasma \u03b1-synuclein predicts cognitive decline in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 88(10):818\u2013824","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7729_CR29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.nbd.2019.02.023","volume":"127","author":"M Shahid","year":"2019","unstructured":"Shahid M et al (2019) An increased rate of longitudinal cognitive decline is observed in Parkinson\u2019s disease patients with low CSF A\u00df42 and an APOE \u03b54 allele. Neurobiol Dis 127:278\u2013286","journal-title":"Neurobiol Dis"},{"issue":"12","key":"7729_CR30","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","volume":"40","author":"NA Jessen","year":"2015","unstructured":"Jessen NA et al (2015) The Glymphatic System: a beginner\u2019s guide. Neurochem Res 40(12):2583\u20132599","journal-title":"Neurochem Res"},{"issue":"147","key":"7729_CR31","doi-asserted-by":"crossref","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ et al (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Transl Med 4(147):147ra111","journal-title":"Sci Transl Med"},{"issue":"4","key":"7729_CR32","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.3390\/biom5042675","volume":"5","author":"W Bobela","year":"2015","unstructured":"Bobela W, Aebischer P, Schneider BL (2015) \u0391lpha-Synuclein as a Mediator in the interplay between Aging and Parkinson\u2019s Disease. Biomolecules 5(4):2675\u20132700","journal-title":"Biomolecules"},{"key":"7729_CR33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40035-019-0147-y","volume":"8","author":"W Zou","year":"2019","unstructured":"Zou W et al (2019) Blocking meningeal lymphatic drainage aggravates Parkinson\u2019s disease-like pathology in mice overexpressing mutated \u03b1-synuclein. Transl Neurodegener 8:7","journal-title":"Transl Neurodegener"},{"issue":"7","key":"7729_CR34","doi-asserted-by":"crossref","first-page":"e41636","DOI":"10.1371\/journal.pone.0041636","volume":"7","author":"CA Hawkes","year":"2012","unstructured":"Hawkes CA et al (2012) Disruption of arterial perivascular drainage of amyloid-\u03b2 from the brains of mice expressing the human APOE \u03b54 allele. PLoS ONE 7(7):e41636","journal-title":"PLoS ONE"},{"key":"7729_CR35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.nbd.2016.05.015","volume":"93","author":"W Peng","year":"2016","unstructured":"Peng W et al (2016) Suppression of glymphatic fluid transport in a mouse model of Alzheimer\u2019s disease. Neurobiol Dis 93:215\u2013225","journal-title":"Neurobiol Dis"},{"issue":"11","key":"7729_CR36","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S1474-4422(18)30318-1","volume":"17","author":"MK Rasmussen","year":"2018","unstructured":"Rasmussen MK, Mestre H, Nedergaard M (2018) The glymphatic pathway in neurological disorders. Lancet Neurol 17(11):1016\u20131024","journal-title":"Lancet Neurol"},{"issue":"2","key":"7729_CR37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10571-016-0343-6","volume":"36","author":"J Ramirez","year":"2016","unstructured":"Ramirez J et al (2016) Imaging the Perivascular Space as a potential biomarker of neurovascular and neurodegenerative diseases. Cell Mol Neurobiol 36(2):289\u2013299","journal-title":"Cell Mol Neurobiol"},{"issue":"5","key":"7729_CR38","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/mds.28473","volume":"36","author":"EK Donahue","year":"2021","unstructured":"Donahue EK et al (2021) Global and Regional changes in Perivascular Space in Idiopathic and Familial Parkinson\u2019s Disease. Mov Disord 36(5):1126\u20131136","journal-title":"Mov Disord"},{"issue":"11","key":"7729_CR39","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/cvr\/cvy113","volume":"114","author":"R Brown","year":"2018","unstructured":"Brown R et al (2018) Understanding the role of the perivascular space in cerebral small vessel disease. Cardiovasc Res 114(11):1462\u20131473","journal-title":"Cardiovasc Res"},{"key":"7729_CR40","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2147\/CIA.S204269","volume":"14","author":"Y Li","year":"2019","unstructured":"Li Y et al (2019) The relationship between blood-brain barrier permeability and enlarged perivascular spaces: a cross-sectional study. Clin Interv Aging 14:871\u2013878","journal-title":"Clin Interv Aging"},{"issue":"3","key":"7729_CR41","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nm.4482","volume":"24","author":"A Montagne","year":"2018","unstructured":"Montagne A et al (2018) Pericyte degeneration causes white matter dysfunction in the mouse central nervous system. Nat Med 24(3):326\u2013337","journal-title":"Nat Med"},{"issue":"10","key":"7729_CR42","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/s41593-018-0234-x","volume":"21","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD et al (2018) The role of brain vasculature in neurodegenerative disorders. Nat Neurosci 21(10):1318\u20131331","journal-title":"Nat Neurosci"},{"issue":"1","key":"7729_CR43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.parkreldis.2008.02.007","volume":"15","author":"I Rektor","year":"2009","unstructured":"Rektor I et al (2009) Vascular pathology in patients with idiopathic Parkinson\u2019s disease. Parkinsonism Relat Disord 15(1):24\u201329","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"7729_CR44","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/gps.4735","volume":"33","author":"M Doiron","year":"2018","unstructured":"Doiron M et al (2018) The influence of vascular risk factors on cognitive function in early Parkinson\u2019s disease. Int J Geriatr Psychiatry 33(2):288\u2013297","journal-title":"Int J Geriatr Psychiatry"},{"issue":"6","key":"7729_CR45","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/ene.12412","volume":"21","author":"MK Sunwoo","year":"2014","unstructured":"Sunwoo MK et al (2014) The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson\u2019s disease. Eur J Neurol 21(6):922\u2013e50","journal-title":"Eur J Neurol"},{"key":"7729_CR46","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.nicl.2018.09.025","volume":"20","author":"M Dadar","year":"2018","unstructured":"Dadar M et al (2018) White matter hyperintensities are linked to future cognitive decline in de novo Parkinson\u2019s disease patients. Neuroimage Clin 20:892\u2013900","journal-title":"Neuroimage Clin"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07729-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07729-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07729-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T05:11:01Z","timestamp":1731301861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07729-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["7729"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07729-9","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"assertion":[{"value":"7 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all patients and their families for their anonymized clinical data to be published for research purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors have no conflict of interest to report. The study does not present any potential conflicts.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}